ReviewHarvard review of psychiatry
Methodology and Reporting of Mobile Heath and Smartphone Application Studies for Schizophrenia.
Review in Harvard review of psychiatry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Geolocation-derived mobility indices and the association with clinical symptoms and functioning in severe mental illness: A multivariate meta-analysis.Journal of psychopathology and clinical science · 2025Pooled it
- Efficacy of User Self-Led and Human-Supported Digital Health Interventions for People With Schizophrenia: A Systematic Review and Meta-Analysis.Schizophrenia bulletin · 2025Pooled it
- Digital biomarkers from geolocation data in bipolar disorder and schizophrenia: a systematic review.Journal of the American Medical Informatics Association : JAMIA · 2019Pooled it
- Potential Benefits of Incorporating Peer-to-Peer Interactions Into Digital Interventions for Psychotic Disorders: A Systematic Review.Psychiatric services (Washington, D.C.) · 2018Pooled it
- Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.Health technology assessment (Winchester, England) · 2022Trial
- Relationships between smartphone social behavior and relapse in schizophrenia: A preliminary report.Schizophrenia research · 2019Trial
- The era of digital mental health interventions: we know they can be effective but are they also safe?BJPsych open · 2025Article
- What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia.Biomolecules · 2024Review
- Bridging the gap from medical to psychological safety assessment: consensus study in a digital mental health context.BJPsych open · 2024Article
- Digital Phenotyping for Mood Disorders: Methodology-Oriented Pilot Feasibility Study.Journal of medical Internet research · 2023Article
- Toward reducing the duration of untreated psychosis in a Latinx community.Journal of consulting and clinical psychology · 2022Article
- Wearables in Schizophrenia: Update on Current and Future Clinical Applications.JMIR mHealth and uHealth · 2022Review
- Implementation of a Mobile DBT App and Its Impact on Suicidality in Transitional Age Youth with Borderline Personality Disorder: A Qualitative Study.International journal of environmental research and public health · 2022Article
- Individualized Intervention to Support Mental Health Recovery Through Implementation of Digital Tools into Clinical Care: Feasibility Study.Community mental health journal · 2022Article
- Open-source Longitudinal Sleep Analysis From Accelerometer Data (DPSleep): Algorithm Development and Validation.JMIR mHealth and uHealth · 2021Article
- Prevention of Suicidal Relapses in Adolescents With a Smartphone Application: Bayesian Network Analysis of a Preclinical Trial Using In Silico Patient Simulations.Journal of medical Internet research · 2021Article
- Sociodemographic characteristics of missing data in digital phenotyping.Scientific reports · 2021Observational
- Toi Même, a Mobile Health Platform for Measuring Bipolar Illness Activity: Protocol for a Feasibility Study.JMIR research protocols · 2020Article
- Mobile App Integration Into Dialectical Behavior Therapy for Persons With Borderline Personality Disorder: Qualitative and Quantitative Study.JMIR mental health · 2020Article
- Real-time Mobile Monitoring of the Dynamic Associations Among Motor Activity, Energy, Mood, and Sleep in Adults With Bipolar Disorder.JAMA psychiatry · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The increasing prevalence of mobile devices among patients of all demographic groups has the potential to transform the ways we diagnose, monitor, treat, and study mental illness. As new tools and technologies emerge, clinicians and researchers are confronted with an increasing array of options both for clinical assessment, through digital capture of the essential behavioral elements of a condition, and for intervention, through formalized treatments, coaching, and other technology-assisted means of patient communication. And yet, as with any new set of tools for the assessment or treatment of a medical condition, establishing and adhering to reporting guidelines-that is, what works and under what conditions-is an essential component of the translational research process. Here, using the recently published World Health Organization mHealth Evaluation, Reporting and Assessment guidelines for evaluating mobile health applications, we review the methodological strengths and weaknesses of existing studies on smartphones and wearables for schizophrenia. While growing evidence supports the feasibility of using mobile tools in severe mental illness, most studies to date failed to adequately report accessibility, interoperability, costs, scalability, replicability, data security, usability testing, or compliance with national guidelines or regulatory statutes. Future research efforts addressing these specific gaps in the literature will help to advance our understanding and to realize the clinical potential of these new tools of psychiatry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.